PhysiologybioRxivPreprint
Liriodendrin Targets PFKFB3 to Suppress Inflammatory Phenotypic Transition and Vascular Remodeling in Pulmonary Hypertension
Qingye Zeng, Zhenzhen Duan, Qian Liu…·Deping Kong
This study identifies liriodendrin as a compound that targets PFKFB3 to reduce inflammation and vascular remodeling in pulmonary hypertension.